UNSPSC 51263113: Bucumolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H23NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier U8WVJ3501L, chemically known as 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-5-methyl-2h-1-benzopyran-2-one but generally known as bucumolol, which bears US NIH Compound Identifier 169787. Bucumolol most often comes in base and hydrochloride forms. European Medicines Agency schedules Bucumolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05954MIG.

UNSPSC 51263113 Bucumolol is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity on record—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with response due July 26, 2023—solicits Naloxone and Safe Drug Deactivation Systems, pharmaceutical and medical-device products unrelated to Bucumolol's pharmaceutical scope. The mismatch between the code's nominal content and the actual work being bought suggests either a data-classification error or minimal recent activity under this code's true definition. State and local procurement offices appear not to be actively sourcing Bucumolol through this UNSPSC classification at present.

The Seminole County opportunity alone does not establish a pattern of activity or geographic spread that would inform targeting strategy under the code. Absent additional recent opportunities properly tagged to UNSPSC 51263113, this code presents insufficient current market signal for business development prioritization in state and local procurement.